Brief ArticleReal-World Eligibility for Second-Line Chimeric Antigen Receptor T Cell Therapy in Large B Cell Lymphoma: A Population-Based Analysis
Under a Creative Commons license
open archive
Key Words
Large B cell lymphoma
Relapsed
Autologous stem cell transplantation
CAR T cell therapy
Cited by (0)
Financial disclosure: See Acknowledgments on page 217.e3.
© 2022 The American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc.